Definition/General

Introduction:
-Cervical clear cell carcinoma is a rare adenocarcinoma characterized by cells with clear cytoplasm, hobnail morphology, and distinctive architectural patterns
-It has strong historical association with in utero DES exposure but can occur sporadically.
Origin:
-Arises from cervical glandular epithelium, often from vaginal adenosis in DES-exposed women
-May also arise sporadically from normal endocervical epithelium
-Shows distinctive clear cell morphology.
Classification:
-WHO Classification recognizes clear cell adenocarcinoma as distinct entity
-Part of Müllerian adenocarcinoma spectrum
-Often HPV-independent.
Epidemiology:
-Peak incidence 15-35 years in DES-exposed
-50-70 years in sporadic cases
-Rare (<2% of cervical cancers)
-Strong DES association historically
-Better prognosis than conventional adenocarcinoma.

Clinical Features

Presentation:
-Abnormal vaginal bleeding
-Clear vaginal discharge
-History of DES exposure important
-May present as cervical or vaginal mass.
Symptoms:
-Abnormal vaginal bleeding (irregular)
-Clear, watery vaginal discharge
-Pelvic pain
-May be asymptomatic initially
-DES exposure history.
Risk Factors:
-In utero DES exposure (major historical risk factor)
-Maternal DES use during pregnancy
-Age (young women with DES exposure)
-Family history.
Screening:
-Standard cervical screening
-Special attention to DES-exposed women
-Annual screening recommended for DES exposure
-Colposcopy with vaginal assessment.

Master Cervical Clear Cell Carcinoma Pathology with RxDx

Access 100+ pathology videos and expert guidance with the RxDx app

Gross Description

Appearance:
-Polypoid or nodular mass
-May arise from vaginal adenosis
-Variable size and location
-Clear to pink coloration possible.
Characteristics:
-Size variable (0.5-8 cm)
-Soft to firm consistency
-May be well-circumscribed
-Clear to gray-white coloration
-Surface may be smooth.
Size Location:
-May arise from cervix or upper vagina
-Anterior wall involvement common in DES cases
-May involve transformation zone.
Multifocality:
-Usually unifocal
-May be associated with vaginal adenosis
-Multiple small foci possible in DES exposure.

Microscopic Description

Histological Features:
-Clear cells with abundant clear cytoplasm arranged in tubular, papillary, and solid patterns
-Hobnail cells with nuclei protruding into lumina characteristic.
Cellular Characteristics:
-Large cells with clear, glycogen-rich cytoplasm
-Hobnail morphology with protruding nuclei
-Moderate nuclear pleomorphism
-Mitotic activity variable.
Architectural Patterns:
-Tubular pattern most common
-Papillary structures with hobnail cells
-Solid areas possible
-Basement membrane may be thickened.
Grading Criteria:
-Grade 1: Tubular pattern predominant
-Grade 2: Mixed patterns
-Grade 3: Solid growth >50%
-Nuclear grade also considered.

Immunohistochemistry

Positive Markers:
-PAX8 positive
-CK7 positive
-Napsin A positive
-HNF-1β positive
-Claudin-4 positive
-EMA positive.
Negative Markers:
-CK20 negative
-TTF-1 negative
-CDX2 negative
-p16 usually negative or patchy
-ER/PR variable.
Diagnostic Utility:
-PAX8 confirms Müllerian origin
-Napsin A and HNF-1β support clear cell differentiation
-p16 negativity suggests HPV-independent.
Molecular Subtypes:
-HPV-independent clear cell carcinoma
-DES-associated vs sporadic types.

Molecular/Genetic

Genetic Mutations:
-PIK3CA mutations common
-ARID1A mutations
-PTEN alterations
-TP53 mutations less common
-KRAS mutations possible.
Molecular Markers:
-Usually HPV-negative
-High HNF-1β expression
-Clear cell gene expression signature
-Lower mutation burden than HPV-positive tumors.
Prognostic Significance:
-Generally better prognosis than conventional adenocarcinoma
-Stage most important factor
-DES-associated cases may have better outcomes.
Therapeutic Targets:
-mTOR pathway inhibitors
-PI3K inhibitors
-Immune checkpoint inhibitors
-Hormonal therapy if receptor positive.

Differential Diagnosis

Similar Entities:
-Endometrioid adenocarcinoma with clear cells
-Metastatic clear cell carcinoma (ovary, kidney)
-Yolk sac tumor
-Arias-Stella reaction.
Distinguishing Features:
-Cervical clear cell: PAX8+, napsin A+, HNF-1β+
-Ovarian clear cell: Similar markers
-Renal clear cell: RCC marker+, PAX2+.
Diagnostic Challenges:
-Distinction from metastatic disease
-Recognition of hobnail morphology
-Assessment of architectural patterns
-DES history importance.
Rare Variants:
-Clear cell with squamous differentiation
-Mixed clear cell and endometrioid
-Clear cell with neuroendocrine features.

Sample Pathology Report

Template Format

Sample Pathology Report

Complete Report: This is an example of how the final pathology report should be structured for this condition.

Specimen Information

[specimen type], measuring [size] cm in greatest dimension

Diagnosis

[diagnosis name]

Classification

Classification: [classification system] [grade/type]

Histological Features

Shows [architectural pattern] with [nuclear features] and [mitotic activity]

Size and Extent

Size: [X] cm, extent: [local/regional/metastatic]

Margins

Margins are [involved/uninvolved] with closest margin [X] mm

Lymphovascular Invasion

Lymphovascular invasion: [present/absent]

Lymph Node Status

Lymph nodes: [X] positive out of [X] examined

Special Studies

IHC: [marker]: [result]

Molecular: [test]: [result]

[other study]: [result]

Prognostic Factors

Prognostic factors: [list factors]

Final Diagnosis

Final diagnosis: [complete diagnosis]